Ablación del cáncer renal por radiofrecuencia

Complete removal of metastatic lesions can contribute to improve clinical prognosis of renal cancer. Nowadays, it is accepted that surgical extirpation of solitary metastases for patients with renal cancer is the only potential for long-term survival. Provided that the metastases could be technical and functionally resected. This review addresses the current evidence about resecable renal cancer metastases at lung, liver, bone, kidney and other organs. The criteria to consider a patient as candidate for resection of metastases are: control of primary tumor, surgical extirpation feasibility and lack of systemic disease. In patients with synchronous metastases, the surgical extirpation should be performed at the same time than nephrectomy. The clinical prognosis is worse when metastases are asynchronous. After the introduction of novel anti-angiogenic agents, surgery is also justified in patients with good responses. Although, this approach remains in the field of investigation.

show abstract

Ablación del cáncer renal por radiofrecuencia

Abstract: Renal tumor radiofrequency ablation has proved an effective therapy with minimal complications. However, it should be used only in selected patients until longer follow-up studies are available.

Cited by 4 publications

References 49 publications

Radiofrecuencia percutánea guiada por ecografía en el tratamiento de masas renales pequeñas

Radiofrecuencia percutánea guiada por ecografía en el tratamiento de masas renales pequeñas

Ultrasound-guided percutaneous radiofrequency ablation for treating small renal masses

Tratamiento quirúrgico de las metástasis del cáncer renal

Contact Info

Product

Resources

About